|Bid||0.0950 x N/A|
|Ask||0.1050 x N/A|
|Day's Range||0.1000 - 0.1000|
|52 Week Range||0.0650 - 0.4500|
|Beta (5Y Monthly)||1.42|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr. 23, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / January 21, 2021 / Pascal Biosciences, Inc. ("Pascal" or the "Company") (TSXV:PAS)(OTC PINK:BIMUF), will present at the first Cannabinoid Derived Pharmaceuticals Industry Review Summit today.
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / December 8, 2020 / December 2, 2020 / Pascal Biosciences Inc.
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / November 10, 2020 / Pascal Biosciences Inc.